We are pleased to welcome Dr. Douglas Sborov to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Sborov was born and raised in Minneapolis, MN, graduated from the University of Wisconsin-Madison with his Bachelors of Science, and completed his medical training at The American University of the Caribbean School of Medicine. Following medical school, he completed his Internal Medicine Residency at the University of Utah, and later his Hematology, Oncology, and Bone Marrow Transplant Fellowship at The Ohio State University. During this time, he obtained his Masters in Medical Science with a concentration in tumor immunology, and completed the National Institutes of Health (NIH) funded T32 training grant with a focus in clinical research and trial development. Over the course of his training, Dr. Sborov developed a passionate interest in the development of novel therapeutics for the treatment of patients with multiple myeloma, as well treating patients undergoing bone marrow transplantation. Dr. Sborov will join the myeloma program at the Huntsman Cancer Institute. We welcome Dr. Sborov to our faculty.... Read MoreInternal Medicine
Division of Hematology & Hematologic Malignancies
The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.
Last year researchers from our division garnered more than $7,000,000 in grant income, presented their data at major conferences, and published their results in prime international journals. This would not be possible without the University of Utah’s outstanding collaborative environment and its strong scientific foundation.
The Division of Hematology and Hematologic Malignancies at the University of Utah is sponsoring an inaugural Multiple Myeloma Symposium to be held September 10, 2016 at the Huntsman Cancer Institute. The symposium will provide an overview of the most recent developments in the field of myeloma therapy. The keynote speaker this year is Dr. Frits van Rhee from the University of Arkansas for Medical Sciences, Myeloma Institute. Dr. Frits van Rhee will discuss Novel Treatments in Multiple Myeloma.... Read MoreInternal Medicine
Dr. Lewis Cantley, Professor of Cancer Biology in Medicine at the Sandra and Edward Meyer Cancer Center at the Weill Cornell Medical College delivered the 2016 George E. Cartwright Memorial Endowed Lecture August 4, 2016. Dr. Cantley presented his research on the signaling pathway of the PI3K kinase and its role in oncogenesis. Dr. Cantley is a highly distinguished scientist and a member of the National Academy of Sciences and the Institute of Medicine of the National Academies.... Read MoreInternal Medicine